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XenopusCanonical Wnt signalling is known to be involved in the regulation of differentiation and proliferation in the
context of endodermal organogenesis. Wnt mediated β-catenin activation is understood to be modulated by
secreted Frizzled-related proteins, such as XsFRP5, which is dynamically expressed in the prospective liver/
ventral pancreatic precursor cells during late neurula stages, becoming liver speciﬁc at tailbud stages and
shifting to the posterior stomach/anterior duodenum territory during tadpole stages of Xenopus
embryogenesis. These expression characteristics prompted us to analyse the function of XsFRP5 in the
context of endodermal organogenesis. We demonstrate that XsFRP5 can form a complex with and inhibit a
multitude of different Wnt ligands, including both canonical and non-canonical ones. Knockdown of XsFRP5
results in transient pancreatic hypoplasia as well as in an enlargement of the stomach. In VegT-injected
animal cap explants, XsFRP5 can induce expression of exocrine but not endocrine pancreatic marker genes.
Both, its expression characteristics as well as its interactions with XsFRP5, deﬁne Wnt2b as a putative target
for XsFRP5 in vivo. Knockdown of Wnt2b results in a hypoplastic stomach as well as in hypoplasia of the
pancreas. On the basis of these ﬁndings we propose that XsFRP5 exerts an early regulatory function in the
speciﬁcation of the ventral pancreas, as well as a late function in controlling stomach size via inhibition of
Wnt signalling.© 2009 Elsevier Inc. All rights reserved.IntroductionDifferent signalling molecules of the Wnt class have been
described to serve important regulatory functions in embryonic
development; they were found to control cell speciﬁcation events as
well as differentiation and proliferation of individual organs (Clevers,
2006). Wnts constitute a family of secreted glycoproteins that bind to
transmembrane receptors of the Frizzled class. The best characterized
Wnt pathway is the so called canonical Wnt pathway that functions
via nuclear accumulation of β-catenin, mainly inﬂuencing cell
proliferation and cell fate (Willert and Jones, 2006). Other branches
of Wnt signalling, referred to as non-canonical, do not rely on
β-catenin and affect cell shape, polarity and motility (Kühl et al.,
2000; Seifert and Mlodzik, 2007). A family of secreted Wnt
antagonists, that share structural similarity with the extracellular
cysteine-rich domain of Frizzled transmembrane receptors, are
termed “secreted Frizzled-related proteins” (sFRPs). The sFRP class
of proteins consists of sFRP1 to sFRP5, Sizzled, Sizzled2, Crescent and
Tlc. The latter four are apparently not present in mammals, but have
been identiﬁed in Xenopus, zebraﬁsh and chicken. Surprisingly, Sizzled
was characterized as a BMP antagonist, which does not appear to bind
Wnts (Lee et al., 2006). In general, sFRPs have been proposed to act as
antagonists by preventingWnt proteins from forming functionalWnt-
Frizzled complexes (Bovolenta et al., 2008; Kawano and Kypta, 2003).l rights reserved.However, there is only limited information available on speciﬁcity and
exact mode of operation for sFRPs in respect to their inhibitory
function on the Wnt signalling activities; sFRPs might also be capable
of agonizing Wnt action, as observed for sFRP1 at a low dose (Uren
et al., 2000).
The endodermal germ layer gives rise to the gastrointestinal tract
with its associated organs, such as thyroid gland, lung, liver, pancreas
and gall bladder. Previous studies have revealed that Wnt signalling
plays important roles in the formation and regionalization of the
vertebrate endoderm. A conditional knockout of β-catenin in the
embryonic endoderm changes cell fate from endoderm to precardiac
mesoderm (Lickert et al., 2002). In amphibia, β-catenin signalling
plays a crucial role in the establishment of the dorsoventral body axis
(Moon and Kimelman,1998). In addition to these very early functions,
canonical Wnt signals were further reported to regulate anterior–
posterior patterning of the primitive gut tube. Overexpression of a
constitutively active form of β-catenin in the murine lung resulted in
ectopic intestinal marker gene expression (Okubo and Hogan, 2004).
The Barx1-mediated secretion of the Wnt antagonists sFRP1 and
sFRP2 is essential during speciﬁcation of the stomach epithelium in
the mouse (Kim et al., 2005), while the double knockout of TCF1 and
TCF4 led to anterior transformations at the stomach–duodenal border
(Gregorieff et al., 2004). In chicken, β-catenin positively regulates
proliferation of hepatic precursor cells; overexpression of β-catenin
resulted in a largely expanded liver, whereas inhibition of β-catenin
led to a hypoplastic liver (Suksaweang et al., 2004). In accordance
with these ﬁndings, it could be shown that mesodermal Wnt2bb is
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zebraﬁsh (Ober et al., 2006). In murine pancreas development, a
bi-phasic effect of β-catenin activity on organ development was
described; early embryonic overexpression led to pancreatic hypo-
plasia, whereas ectopic expression of β-catenin at E13.5 resulted in a
strong increase in pancreas mass (Heiser et al., 2006).
In Xenopus, an early role for Wnt signalling in the anterior–
posterior patterning of the endodermhas been revealedmore recently
by both inhibition as well as ectopic activation of β-catenin activity in
the endoderm of gastrula stage embryos; ectopic expression of liver
and pancreas marker gene expression in the posterior endodermwas
achieved by inhibition, and suppression of the same genes was
observed upon over-activation of canonical Wnt signalling. On the
basis of these results it was proposed that endoderm patterningmight
be regulated in striking similarity to the anterior–posterior patterning
of the central nervous system, that relies on inhibition of Wnt
signalling anteriorly and higher levels posteriorly (McLin et al., 2007).
One member of the sFRP class of Wnt antagonists in Xenopus,
namely XsFRP5, was shown to be expressed in a pattern overlapping
with and extending dorsally to the ﬁeld of liver precursor cells at late
neurula stage; these expression characteristics are maintained to
tailbud stages of development. XsFRP5 expression shifts to other
endodermal tissues coincident with the posterior stomach and
anterior duodenum during later development. It is however never
detected in the pancreas during later stages (Pilcher and Krieg, 2002).
The mouse orthologue, Sfrp5, is expressed already in the anterior
visceral endoderm and later in the foregut endoderm, which will give
rise to the liver (Finley et al., 2003). Nevertheless, Sfrp5 depletion does
not appear to affect axis formation nor Hex expression as a molecular
marker for liver development (Leaf et al., 2006); a weak effect on
somitogenesis has been reported most recently in Sfrp1/Sfrp2/Sfrp5
compound knockout mice (Satoh et al., 2008).
The aim of this study was to functionally characterize XsFRP5
during gastrointestinal tract development in Xenopus. We report that
XsFRP5 can inhibit a broad range of canonical and non-canonical Xwnt
proteins. Furthermore, we reveal a regulatory function for XsFRP5
during endodermal organogenesis and propose that XsFRP5 controls
speciﬁcation of the ventral pancreatic anlage as well as proliferation of
the stomach epithelium, at least in part via inhibition of Xwnt2b.
Materials and methods
Embryo culture and microinjection
Xenopus embryos were obtained from HCG-injected females using
standard techniques and staged according to Nieuwkoop and Faber
(1967). Capped mRNA for microinjection was transcribed in vitro
(mMessage mMachine Kit, Ambion) and puriﬁed chromatographi-
cally (RNeasy, Qiagen). Enzymes used for linearization and transcrip-
tion as well as the injected amounts per embryo were as follows:
pCS2+/GFP (NotI; SP6; 500 pg), pCS2+/5′UTR–XsFRP5–GFP (NotI;
SP6; 500 pg), pCS2+/hFz5 (NsiI; Sp6; 50 pg), pCS2+/VegT (NotI;
SP6; 200 pg), pCS2+/XsFRP5 (NotI; SP6: 50, 100, 200 pg), pCS2+/
XsFRP5-HA (NotI; SP6; 500 pg), pcDNA3/XsFRP2 (XhoI; T7; 200,
400 pg), pXT7/Xwnt2b (SalI; T7; 60 pg), pCS2+/MT-Xwnt2b (NotI;
SP6; 500 pg), pSP64T-Xwnt3a (NcoI; SP6; 10 pg), pCS2+/MT-Xwnt3a
(NotI; SP6; 500 pg), pSP64T-Xwnt4 (SalI; SP6; 5 pg), pCS2+/
MT-Xwnt4 (NotI; SP6; 500 pg), pSP64T-Xwnt5a (XbaI; SP6; 5 pg),
pCS2+/MT-Xwnt5a (NotI; SP6; 500 pg), pSP64T-Xwnt8 (BamHI; SP6;
10 pg), pCS2+/MT-Xwnt8 (NotI; SP6; 500 pg), pSP64T-Xwnt8b (SalI;
SP6; 10 pg), pCS2+/MT-Xwnt8b (NotI; SP6; 500 pg), pCS2+/Xwnt11
(SacI; T7; 5 pg), pCS2+/MT-Xwnt11 (NotI; SP6; 500 pg), pCS2+/
Xwnt11R (NotI; SP6; 5 pg), and pCS2+/MT-Xwnt11R (NotI; SP6;
500 pg). For axis duplication assays, embryos were injected margin-
ally into one ventral blastomere at the four cell stage and nuclear LacZ
mRNA was used to equilibrate the injected RNA quantities. Axisduplication assays for each different Xwnt were at least performed
twice. Morpholino antisense oligonucleotides (MOs) were ordered
from GeneTools and injected at the four/eight cell-stage into all four
blastomeres at the vegetal pole. The Xwnt2b splice-morpholino
(SpliMO) is directed against the exon3/intron3 junction and
Xwnt2b-SpliMO2 is directed against intron3/exon4 junction of Xe-
nopus laevis Wnt2b. Intron3 was PCR-ampliﬁed from genomic DNA,
sub-cloned and sequenced. Sequences of the MOs are: XsFRP5-MO1
(5′-ATCGCATGATTTCTCCAAAAAGTGG-3′); mmMO1 (5′-ATGGCATCATATCTC-
GAAAAACTGG-3′); XsFRP5-MO2 (5′-TTTAACCCAAAGGCTTATCCTCCTG-
3′); Xwnt2b-SpliMO (5′-CACGCTCAGCAAGACTTACCATTC-3);
Xwnt2b-MO (5′-GTATTAAAATATAAGCAAAA-TGCAT-3′); Xwnt2b-
SpliMO2 (5′-TTTACTGCCTGTAAGATAGGAAAAA-3′). Injected amounts
were 5 ng of the XsFRP5-MO1 andmmMO, 2 ng of XsFRP5-MO2, 20 ng
of Xwnt2b-SpliMO and Xwnt2b-MO as well as 10 ng Xwnt2b-
SpliMO2. 150 pg nuclear LacZ mRNA was co-injected as a lineage
tracer.
Microdissection of stage 40 gut tubes
Embryos were cultured until stage 40 and after 30 min preﬁxing in
MEMFA, gut tubes were explanted as described previously (Chalmers
and Slack, 1998). Explants were reﬁxed for 15 min in MEMFA and
either X-Gal stained or transferred to and stored in ethanol.
Whole-mount in situ hybridisation
The embryos and explants were stained for X-Gal activity as
described (Hardcastle and Papalopulu, 2000). Whole-mount in situ
hybridisation was performed as described previously (Harland, 1991;
Hollemann et al., 1999) with Digoxigenin-UTP (Roche) labelled
antisense probes. The following antisense probes were prepared as
described previously: Ptf1a/p48 and XlHbox8 (Chen et al., 2004),
XPDIp (Afelik et al., 2004). Enzymes used for linearization and in vitro
transcription are indicated for: pBK-CMV-Fibrinogen (NcoI; T3), pBSK-
Sox2 (EcoRI; T7), pGEMT-XsFRP5 (SphI; SP6), pCS2+/MT-Xwnt2b
(EcoRI; T7), pGEMT-Xwnt5a (NcoI; SP6), and pCS2+/Xwnt11
(BamHI; T7).
pH3 staining
Control andmorpholino-injected embryos were ﬁxed in MEMFA at
stage 32, stage 37/38 and stage 40 (gut tube explants), transferred to
Dent's solution and stored at−20 °C for 1 week. The pH 3 assay was
performed as described previously (Dent et al., 1989). As ﬁrst antibody
we used the rabbit anti-pH3 antibody from Biomol and as secondary
antibody the goat anti-rabbit IgG alkaline phosphatase-coupled
antibody from Sigma.
Vibratome sections
30 μm vibratome sections were prepared as described previously
(Hollemann and Pieler, 1999) using a Leica VT1000S Vibratome.
Co-immunoprecipitation
XsFRP5 and Xwnt constructs were PCR-ampliﬁed and subcloned
into pCS2+/HA or pCS2+/6xMyc, respectively. Embryos were
injected animally into both blastomeres at the two cell stage and
cultured until stage 10.5. Co-IP was performed as described (Djiane
et al., 2000), using anti-HA IgG (MMS-101P, Covance).
Animal cap dissection and RT-PCR analysis
Xenopus embryos were injected animally into both blastomeres at
the two cell stage. Animal caps were isolated at stage 8/9 and cultured
Fig. 1. XsFRP5 inhibits dorsal axis duplication induced by various canonical and non-canonical Xwnt proteins. Axis duplication was achieved by injecting 60 pg Xwnt2b (A), 10 pg
Xwnt3a (B), Xwnt8 (C) and Xwnt8b (D) mRNA as well as 5 pg Xwnt4 (E), Xwnt5a (F), Xwnt11 (G) and Xwnt11R (H) mRNA into one of two ventral blastomeres at the four cell stage;
50 pg hFz5 mRNAwere co-injected in (E–H). 10 (+), 50 (+) or 100 pg (++) XsFRP5 mRNAwere co-injected, as indicated. Embryos were scored for dorsal axis duplication at early
tailbud stage. The signiﬁcance of values obtained for reduction of Wnt-mediated axis duplication was calculated using standardised normal distribution and is indicated with
asterisks.
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using Trizol and treated with DNaseI. All samples were controlled for
genomic DNA contamination by 30 cycles of Histone H4-speciﬁc PCR
without the use of reverse transcriptase. cDNA was prepared using
random hexamer primers and was analysed by semi-quantitative
RT-PCR for marker gene expression using the GoTaq Kit (Promega).
The following primer sequences and cycle numbers were published
elsewhere: Histone H4, Transthyretin, Insulin and XlHbox8 (Chen
et al., 2003), Xbra (Batut et al., 2005), XPDIp (Afelik et al., 2004),
XTwist (Pan et al., 2007), and Sox2 (Nitta et al., 2006). For other
marker genes, the primer pairs and cycle numbers were: Ptf1a/p48
(fw: 5′-GAGAAGCGACTGTCCAAG-3′; rev: 5′-CATCAGTCCATGAG-
AGAG-3′; 33 cycles), Xnr3 (fw: 5′-GACCAGGGGAAAGAGGTT-3′; rev:
5′-GGGATCAGGTTTAGCATGAG-3′; 32 cycles), XsFRP5 (fw: 5′-
AGGTCCTTAAAGCAGGGAAG-3′; rev: 5′-GCGATGGTGGCACTTAAAG-
3′; 34 cycles), and Xwnt2b (fw: 5′-ACTGGGAGCAAGGGTTATCTGTG-
3′; rev: 5′-GACCCCGTGGCACTTAC-3′; 33 cycles).
Chemical treatment of animal cap explants
Animal cap explants were treated with 5 μM retinoic acid (RA) at
stage 9 for 1 h, as described previously (Pan et al., 2007). Animal caps
were treated with 1 μM BMS453 at stage 9 for 1 h in the dark. Control
caps were treated with ethanol or DMSO, respectively.
Results
XsFRP5 functions as an inhibitor of canonical and non-canonical
Wnt signalling
sFRPs have been proposed to function both as agonists and as
antagonists of Wnt signalling activity (Bovolenta et al., 2008; Kawano
and Kypta, 2003). Bovine sFRP5 has previously been reported to exert
a weak inhibitory activity in Xenopus Wnt8 induced secondary bodyFig. 2. XsFRP5 functions as an inhibitor of canonical and non-canonical Wnt signalling. (A) X
Xwnt2b or 10 pg Xwnt3a, Xwnt8 and Xwnt8b mRNAs were injected with or without 100 pg
were isolated at stage 8 and grown to the equivalent of stage 11.5. RNA preparations were an
(B) Overexpression of XsFRP5 interferes with gastrulation movements. Embryos were inject
when sibling control embryos had reached stage 12 and stage 25, respectively. (C) Xwnt pr
animally at the two cell stage and embryos were harvested at gastrula stage. Immunoprec
HA-tagged XsFRP5 and the samples were analysed by Western Blot. Actin was used as
IP=immunopellet, IB=immunoblot.axis formation in Xenopus embryos (Chang et al., 1999). In order to
analyse the activity and speciﬁcity of Xenopus sFRP5 more syste-
matically, we employed four different assay systems. Firstly, we tested
the effect of XsFRP5 on the ability of a number of different canonical
and non-canonical Xenopus Wnts to induce secondary axis formation
in whole embryos and, secondly, to induce canonical Wnt target gene
transcription in animal cap explants. Thirdly, we analysed the
morphological effects of XsFRP5 overexpression on gastrulation
movements, which are known to be regulated by endogenous, non-
canonical Wnt signalling, and, ﬁnally, we also tested integration of
XsFRP5 into one complex with the same panel of Wnts in co-
immunoprecipitation assays from microinjected Xenopus embryos.
Of the four different canonical Wnts analysed, two, namely
Xwnt2b and Xwnt8b, were found to be signiﬁcantly inhibited (more
than twofold) in respect to their axis inducing activity already at the
lowest dose of XsFRP5 tested (Figs. 1A, D); a third one, Xwnt8,
revealed a signiﬁcant response at the intermediate dose, while the
fourth one, Xwnt3a, was only weakly inhibited even at the highest
dose tested (Figs. 1B, C). Xnr3 gene transcription is known to be
stimulated by β-catenin mediated Wnt signalling in microinjected
animal cap explants (McKendry et al., 1997); in this scenario, XsFRP5
completely blocks Xwnt2b, Xwnt8 and Xwnt8b, while Xwnt3a was
only moderately inhibited (Fig. 2A). Thus, there is a very good
correlation of results obtained in these two ﬁrst assays for the effects
of XsFRP5 on canonical Wnt signalling.
The non-canonical Wnts require co-injection of hFz5 in order to
elucidate their axis-inducing activities (He et al., 1997). As for the
canonicalWnt ligands, multiple of the non-canonical ones were found
to be inhibited signiﬁcantly by XsFRP5: Xwnt4 already at the lowest
dose tested, Xwnt5a and Xwnt11R at intermediate doses and Xwnt11
only moderately, even at the highest dose tested (Figs. 1E–H). The
ability of XsFRP5 to inhibit non-canonical Wnts should also affect
gastrulation movements, as they are known to be regulated by non-
canonical Wnt signalling. Vegetal injection of XsFRP5 at the two cellsFRP5 can suppress Xwnt-induced Xnr3 gene expression in animal cap explants. 60 pg
XsFRP5 mRNA animally into both blastomeres at the two cell stage. Animal cap explants
alysed by semi-quantitative RT-PCR for transcriptional activation of the genes indicated.
ed vegetally into both blastomeres with 100 pg or 200 pg XsFRP5 mRNA and harvested
oteins co-precipitate with XsFRP5. As indicated, tagged fusion constructs were injected
ipitation was performed from embryonic extracts using an antibody directed against
loading control for the input. I=input (10% crude extract), P=preclearing pellet,
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shape as compared to sibling control embryos, a phenotype that is
indicative for defects in convergent extension cell movements
(Fig. 2B). When such XsFRP5-injected embryos were grown to later
stages of development, they exhibited a severely shortened A–P body
axis; similar phenotypes have been described for other proteins that
interfere with non-canonical Wnt signalling (Kühl et al., 2001; Tahinci
et al., 2007; Yamanaka et al., 2002). These observations provide a clear
further indication for XsFRP5 being able to inhibit non-canonical Wnt
signalling in early Xenopus embryos. Thus, in summary, XsFRP5 can
function as an inhibitor of both canonical and non-canonical Wnt
signalling, and it appears to possess signiﬁcantly different relative
efﬁciencies in respect to its inhibitory effects on the eight different
Wnt ligands employed in the above assays.
The inhibitory activities of XsFRP5 in the axis duplication assay
could reﬂect complex formation with Wnt ligands and perhaps other
proteins, or they could be the consequence of a more indirect
mechanism. To test this hypothesis, epitope-tagged versions of various
Xwnt proteins were analysed for their ability to co-immunoprecipitate
from injected embryonic extracts (Fig. 2C). In most assays, the WntFig. 3. Knockdown of XsFRP5 expression by morpholino injection leads to a hypoplastic ve
analysis by whole-mount in situ hybridisation. 5 ng mmMO1 or a combination of 5 ng MO1
stage. LacZ activity was used as a lineage tracer. Whole-mount in situ hybridisationwas perfo
indicate the width of the Sox2 expression domain (P–R). The red arrowheads mark the ven
MO1+MO2-injected embryos stained for Ptf1a/p48. The blue arrows indicate the dorsal pan
pancreatic anlagenwas quantiﬁed in control, mmMO- and MO1+MO2-injected embryos sta
Signiﬁcance was calculated using Student's T Test and is marked with asterisks. (X) Vibratom
quantiﬁed for proliferative cells using pH3-labelling. 10 consecutive sections of 3 embryos/ex
in the stomach/pancreas/liver area of stage 40 gut explants. The mean value of pH3+ cells i
marked with asterisks.proteins gave rise to several electrophoretically distinct signals in the
input samples, possibly representing the different processing events
leading to the formation of biologically active signalling molecules.
Xwnt2b, 3a, 4, 8, 11 and 11Rwere found to co-precipitate in signiﬁcant
quantities with XsFRP5, whereas Xwnt5a and Xwnt8b were only very
weakly detected. Thus, XsFRP5 is able to form complexes including
both canonical and non-canonical Wnts. This is consistent with the
general conclusion drawn from the above experiments testing for
biological activities. However, there are several exceptions: Xwnt8b,
was efﬁciently inhibited in the axis duplication and animal cap assays,
while it was only very weakly co-immunoprecipitated; conversely,
Xwnt3a was found to be grossly complexed with XsFRP5, while being
only moderately inhibited in the functional assays.
Knockdown of XsFRP5 results in a hypoplastic ventral pancreatic anlage
as well as in stomach enlargement
In order to suppress XsFRP5 translation, two different antisense
morpholino oligonucleotides were designed, one spanning the region
of the start codon (MO1) and the second one (MO2) targeting antral pancreas and stomach enlargement. (A–U) Endodermal marker gene expression
and 2 ng MO2 were injected into the vegetal pole of all four blastomeres at the four cell
rmed with stage 32 (A–F), stage 37/38 (G–L) and stage 40 embryos (M–U). The red bars
tral pancreatic anlage (C, F, I, L, O). (V) Vibratome sections of stage 37/38 control and
creatic anlage and the red arrows mark the ventral anlagen. (W) The size of the ventral
ined for Ptf1a/p48 or XPDIp. The average pixel number in the controls was set to 100%.
e sections of stage 32 and stage 37/38 embryos, as well as stage 40 gut explants were
plants were scored for pH3+ cells in the anterior endoderm at stages 32 and 37/38, and
n the controls was set to 100%. Signiﬁcance was calculated using Student's T Test and is
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a ﬁve nucleotide mismatch version of MO1 (mmMO1) served as a
control (Supplementary ﬁg. 1A). All morpholinos were tested in vitro
and in vivo for their ability to block XsFRP5 protein synthesis. Both
MO1 and MO2 reduced XsFRP5 protein translation in vitro; in
combination, they completely blocked translation, while the mis-
matched morpholino had no signiﬁcant effect (Supplementary
ﬁg. 1B). For the purpose of additional control experiments, GFP was
fused to the XsFRP5–5′UTR and injected into early cleavage stages
with or without the different MOs. Injection of MO1 and MO2 blocked
GFP expression completely, whereas mmMO1 had no signiﬁcant
effect; expression of a GFP construct withoutmorpholino binding sites
was not affected by any of these manipulations (Supplementary
ﬁg.1C). Thus, bothMO1 andMO2 function speciﬁcally in the in vitro as
well as in the in vivo situation.
To knockdown expression of XsFRP5 in Xenopus embryos, a
combination of MO1 and MO2 was injected vegetally into all four
blastomeres at the four/eight cell stage to target the presumptive
endoderm, and resulting effects on endodermal organogenesis were
monitored by in situ hybridisation (Figs. 3A–U). Knockdown of
XsFRP5 resulted in inhibition of pancreas speciﬁcation as revealed
by reduced endodermal Ptf1a/p48 expression at stage 32 (Figs. 3C and
W); at stage 37/38, inhibition of Ptf1a/p48 expression in the ventral
pancreas persisted, while dorsal pancreas formation, as well as otherFig. 4. XsFRP5 can substitute for retinoic acid in respect to the induction of exocrine cell diffe
and 50, 100 or 200 pg XsFRP5 mRNA animally into both blastomeres at the two cell stage a
control embryos had reached stage 40 and analysed by semi-quantitative RT-PCR. Treatmen
cannot phenocopy the XsFRP5-induced pancreatic marker gene expression in VegT injected
plus 200 and 400 pg XsFRP2 mRNA respectively and treated as stated above.Ptf1a/p48 expression domains in retina and hindbrain, were largely
unaffected in XsFRP5morphant embryos (Figs. 3I, V andW). XlHbox8,
a second pancreatic precursor cell marker that is additionally
expressed in duodenum and posterior stomach, similarly reveals
early pancreatic hypoplasia, as well as a partial loss of expression in
the duodenum (Figs. 3F and L). Even though the inhibitory effects on
pancreas development upon XsFRP5 knockdown appear to be most
pronounced at speciﬁcation stages (stage 32), they also correlate with
a smaller pancreas size in later development (stage 40), as shown by
reduced XPDIp staining, marking differentiated exocrine pancreatic
tissue (Figs. 3O and W). To analyse effects on stomach development,
endoderm explants from stage 40 were analysed for Sox2 expression.
At this stage, Sox2marks the oesophagus, the stomach and an anterior
portion of the duodenum (Fig. 3P). Loss of XsFRP5 leads to an
enlargement of the stomach (Fig. 3R), as compared to the uninjected
control embryos. Fibrinogen, which is expressed in liver and intestine
of stage 40 embryos, remains undisturbed (Figs. 3S–U). Since organ
enlargement could be the result of increased proliferation, we further
compared morphant and control embryos for effects on phospho-
Histone H3 (pH3) staining in the anterior endoderm of stages 32 and
37/38 embryos, as well as in the stomach/liver/duodenum territory
of stage 40 endodermal explants; knockdown of XsFRP5 correlates
with a signiﬁcant increase in the number of proliferating cells in the
anterior endoderm of stage 32 embryos (Fig. 3X). Thus, knockdown ofrentiation in VegT injected animal caps. (A, B) Embryos were injected with 200 pg VegT
nd animal cap explants were isolated at stages 8 to 9. The explants were cultured until
t with 5 μM retinoic acid or 1 μM BMS453 was performed for 1 h at stage 9. (C) XsFRP2
animal cap explants. Embryos were injected with 200 pg VegT plus 200 pg XsFRP5, or
333K. Damianitsch et al. / Developmental Biology 329 (2009) 327–337XsFRP5 results in pancreatic hypoplasia and stomach enlargement, as
well as in increased proliferative activity in the anterior endoderm
during pancreas speciﬁcation stages of development.
XsFRP5 can substitute the need for retinoic acid in
exocrine differentiation
As we have reported in a previous study, combined VegT injection
and retinoic acid (RA) treatment of animal cap explants induces both
exo- and endocrine-speciﬁc pancreatic marker gene expression, while
injection of VegT alone is sufﬁcient to induce the expression of
duodenal and hepatic marker genes (Chen et al., 2004; Pan et al.,
2007; see also Fig. 4A, lanes 3 and 8).We observed that both naïve and
VegT injected explants express a variety of different canonical and
non-canonical Wnt ligands (data not shown); therefore, a possible
inﬂuence of XsFRP5 on this system was analysed. Co-injecting
increasing amounts of XsFRP5 along with VegT, without adding
exogenous RA, led to a robust and dose-dependent induction of the
pancreatic precursor cell markers Ptf1a/p48 and XlHbox8, as well as
of the exocrine differentiation marker XPDIp. Insulin expression, on
the other hand, could not be induced (Fig. 4A, lanes 4–6). Expression
of the liver differentiation marker Ttr did not change when VegT and
XsFRP5 were co-expressed, as compared to VegT injected animal cap
explants. Sox2 expression was weakly induced in VegT injected caps
by co-injection of low amounts of XsFRP5, whereas higher amounts of
XsFRP5 abolished Sox2 expression. Thus, XsFRP5 can substitute for the
requirement of retinoic acid in respect to the induction of exocrine but
not of endocrine pancreatic cell differentiation.
To address the question if exocrine pancreatic marker gene
activation in this system by XsFRP5 would still require downstream
retinoic acid signalling, VegT/XsFRP5 co-injected animal cap explants
were treated with the retinoic acid antagonist BMS453 and analysed
for pancreatic marker gene expression when sibling embryos had
reached organogenesis stage. Ptf1a/p48 as well as XPDIp expression
was strongly reduced upon BMS453-treatment in XsFRP5/VegT co-
injected animal cap explants (Fig. 4B). To further address the questionFig. 5. Comparative expression analysis of XsFRP5 and different Xwnts. DIG-UTP labelled an
were used for whole-mount in situ hybridisation of stage 35 embryos (A, D, G, J), stage 40 e
sections are shown in A′–K′. he=heart, li=liver, lu=lung, st=stomach/duodenum, oe=if the observed induction of pancreatic marker genes in VegT-injected
animal caps is speciﬁc for XsFRP5, the closely related XsFRP2 was
tested in the same assay. The XsFRP5-mediated induction of Ptf1a/p48
and XPDIp expression in VegT-injected animal caps could not be
phenocopied by co-injection of XsFRP2, not even at an increased
concentration (Fig. 4C). Thus, in conclusion, these experiments reveal
that XsFRP5 can speciﬁcally substitute for the requirement for RA in
respect to the speciﬁc induction of exocrine pancreatic marker gene
expression in VegT injected animal cap explants, probably acting
upstream of the RA signalling pathway.
Xwnt2b is a putative target for XsFRP5 in the context of
endoderm patterning
In order to identify a putative target Wnt ligand for XsFRP5 in the
context of stomach/duodenum/pancreas development (endoderm
patterning), we compared the spatio-temporal expression pattern of
XsFRP5 with the ones of the various different Wnt proteins tested
above, since putative in vivo Wnt targets should be expressed
complementary to or overlapping with XsFRP5. Depicted in Fig. 5
are only those Xwnts, which were signiﬁcantly inhibited in the axis
duplication assays (Fig. 1), co-precipitated efﬁciently with XsFRP5
(Fig. 2C) and revealed overlapping or complementary expression
domains with XsFRP5 during organogenesis stages. Consistent with
the original description by Pilcher and Krieg (2002), we ﬁnd XsFRP5 to
be expressed in the liver diverticulum at stage 35 and in stomach/
anterior duodenum at stage 40. Conﬁrming and extending the earlier
description of Xwnt2b expression (Landesman and Sokol, 1997), stage
35 embryos reveal bilateral, mesodermal staining in a narrowly
deﬁned stripe of cells lying in juxtaposition to the liver/pancreas/
stomach forming endoderm (Fig. 5D); stage 40 endodermal explants
exhibit strong anterior staining in the developing lung (Fig. 5F). At
stage 35, Xwnt5a is expressed as published earlier (Moon et al., 1993),
demarcating the oesophagus, lung and anterior stomach at stage 40
(Figs. 5G–I). In stage 35 embryos, Xwnt11R is expressed in the somites
and in the ﬁrst branchial arch (Garriock et al., 2005). At stage 40, wetisense probes against XsFRP5 (A–C), Xwnt2b (D–F), Xwnt5a (G–I) and Xwnt11R (J–L)
mbryos (B. E, H, K) and stage 40 gut tube and heart-explants (C, F, I, L). Corresponding
oesophagus, and pr=pronephros.
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expression in the oesophagus (Fig. 5L).
To address the question if Xwnt2b, which is expressed in stage 35
Xenopus embryos in a pattern complementary to the one of XsFRP5,
and which we have found to interact with and to be efﬁciently
inhibited by XsFRP5, could be its in vivo target, we knocked down
Xwnt2b signalling activity in the Xenopus embryo. For this purpose,
three different antisense morpholino oligonucleotides were gener-
ated; a splice-morpholino directed at the exon3/intron3 transition
sequence of the Xwnt2b mRNA (2b-SpliMO), a second splice-
morpholino directed at the intron3/exon4 transition (2b-SpliMO2)
and a third MO directed at the start site of translation (2b-MO) were
designed (see Materials and methods for details). RT-PCR analysis of
SpliMO injected embryos (Fig. 6A) reveals signiﬁcantly reduced levels
of fully spliced Xwnt2b mRNA and appearance of two additional,
longer RNA products which contain sequence elements of intron3
joined to exon3 from the Xwnt2b gene (data not shown); the
appearance of a smaller RT-PCR product could reﬂect SpliMO-induced
skipping of exon3. In addition, the overall quantity of these different
forms of Xwnt2b mRNA appears to be reduced, indicative of
degradation of Xwnt2b mRNA that is not properly spliced. RNAFig. 6. Knockdown of Xwnt2b expression causes foregut hypoplasia. (A) Speciﬁcity control for
blastomeres at the two cell stage and embryos/animal cap explants were analysed for the Xw
Low Range (Fermentas). (B–I) Marker gene expression analysis after Xwnt2b knockdown by
vegetal pole of all four blastomeres at the four-cell stage. LacZ activitywas used as a lineage tra
40 embryos (D–I). The red arrowheadsmark the hypoplastic pancreas (E) and stomach/duod
bars indicate thewidth of the Sox2 expression domain (F, G). (J) Vibratome sections of contro
cells using pH3-labelling. 10 consecutive sections of 3 embryos/explants were scored for pH3
liver area of stage 40 gut explants. The mean value of pH3+ cells in the controls was set to 1
Quantiﬁcation of the size of the Sox2-expression domain in control, MO1+MO2-, Xwnt2b-
injected gut explants. The average pixel number in the controls was set to 100%. Signiﬁcancepreparations from 2b-SpliMO2 injected embryos equally reveal
overall reduced levels of properly spliced Xwnt2b mRNA as well as
the appearance of a longer, presumably incompletely spliced RNA
variant (Supplementary ﬁg. 2B). 2b-MO is a speciﬁc inhibitor of
Xwnt2b translation in vitro (Supplementary ﬁg. 2A).
Injection of these different MOs into the prospective endoderm
and mesoderm (as revealed by β-Gal tracing), followed by analysis of
marker gene expression of stage 40 embryos in pancreas, stomach,
liver and intestine revealed that Xwnt2b knockdown results in a
size reduction of the stomach (Figs. 6F, G, K and Supplementary
ﬁgs. 2C–E), as well as in pancreatic hypoplasia, affecting both dorsal
and ventral anlagen (Figs. 6D, E and Supplementary ﬁgs. 2F–H).
Hepatic and intestinal expression of ﬁbrinogen was unaffected
(Figs. 6H, I and Supplementary ﬁgs. 2I–K). Size reduction of the
stomach as a result of Xwnt2b knockdown could be explained by a
positive function for Xwnt2b in proliferation control. In order to
address this issue, the absolute number of proliferating cells was
determined on sections prepared from embryos stained for pH3. It
turns out that the total number of endodermal pH3 staining is indeed
markedly reduced in stage 37/38 and 40, but not in stage 32 embryos
upon injection of 2b-SpliMO (Fig. 6J). In line with these late effects onthe Xwnt2b-SpliceMorpholino (SpliMO). 20 ng SpliMOwere injected animally into both
nt2b transcript by RT-PCR at different developmental stages.M=Fastruler™DNA ladder
whole-mount in situ hybridisation. A total amount of 20 ng SpliMOwas injected into the
cer.Whole-mount in situ hybridisationwas performedwith stage 37/38 (B, C) and stage
enum (I) as detected by staining with XPDIp and ﬁbrinogen probes, respectively. The red
l and SpliMO-injected embryos, as well as of gut explants were analysed for proliferative
+ cells in the anterior endoderm at stages 32 and 37/38, and in the stomach/pancreas/
00%. Signiﬁcance was calculated using Student's T Test and marked with asterisks. (K)
SpliMO- and double injected gut explants as well as Xwnt2b-MO and Xwnt2b-SpliMO2
was calculated using Student's T Test and marked with asterisks.
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signiﬁcantly affected in Xwnt2bmorphant embryos (Figs. 6B, C). Thus,
as compared to XsFRP5 knockdown, partial loss of Xwnt2b yielded a
reciprocal phenotype in respect to stomach size and proliferation
activity in the endoderm.
Discussion
We have provided direct experimental evidence that a member of
the secreted Frizzled-related protein family, Xenopus sFRP5, can
assemble into one complex with and inhibit the signalling activity of
multiple Wnt ligands, thereby interfering with both, canonical and
non-canonical signalling. Knockdown of XsFRP5 results in early,
transient hypoplasia of the pancreas. Furthermore, reduced XsFRP5
activity in Xenopus embryos leads to stomach enlargement. Xwnt2b,
which is inhibited by XsFRP5 in its ability to activate canonical Wnt
signalling in the Xenopus embryo and co-immunoprecipitate with
XsFRP5 from programmed embryonic extracts, is also expressed in a
complementary pattern with XsFRP5 during tailbud stages in the
stomach/liver/pancreas territory. Knockdown of Xwnt2b results in
hypoplasia of stomach and pancreas in tadpole stages of development.
We also found that XsFRP5 can substitute for RA in VegT-programmed
animal cap explants in respect to the induction of exocrine pancreatic
marker gene expression.
XsFRP5 acts as a multi-speciﬁc inhibitor of canonical and non-canonical
Wnt signalling
While all of the canonical and non-canonical Wnts analysed in this
study were inhibited at least to some extent by high doses of XsFRP5
in the axis duplication assay, not all of these signalling molecules were
found to co-precipitate efﬁciently with XsFRP5; the axis inducing
activity of Xwnt8b, for example, is already signiﬁcantly inhibited at
the lowest dose of XsFRP5 tested, while it is only very weakly
detectable in a complex with XsFRP5 in the co-immunoprecipitation
assay. This ﬁnding raises the possibility that XsFRP5 could make use of
different modes of operation as Wnt antagonist. In addition to
preventing Wnt binding to the cognate receptors by forming a
common complex (with or without other proteins), it could also bind
to and inhibit other proteins involved in Wnt mediated activation of
signal transduction, such as the Wnt receptors themselves, as has
been proposed earlier (Baﬁco et al., 1999), or known co-receptors,
such as LRP5/6. The latter, indirect mechanism for Wnt inhibition has
indeed been deﬁned for the Wnt antagonist Dkk (Mao et al., 2001).
Similarly, efﬁcient co-immunoprecipitation is not predictive for
efﬁcient inhibition of secondary axis induction, as in the case of
Xwnt3a, which is pulled down efﬁciently but only marginallyFig. 7. A schematic drawing illustrating XsFRP5 function during endodermal organogenesi
population during gastrulation. During early somite stages XsFRP5 expression in the endoder
putative WntX, thereby permitting pancreas speciﬁcation. At tadpole stage, XsFRP5 expres
activities in the endoderm.inhibited; thus, in addition to binding the Wnt ligands themselves,
XsFRP5 may interact with multiple components of the Wnt signal
receiving and transducingmachinery, and each one of these individual
interactions could contribute to efﬁciency and speciﬁcity of Wnt
inhibition. However, irrespective of the exact molecular mechanism of
its function, XsFRP5 is an antagonist that works on multiple Wnt
ligands, both canonical and non-canonical ones; a positive, synergistic
activity onWnt signalling was not detected for any of the Wnt ligands
tested here. These properties make sFRP5 also an interesting
candidate reagent in preventing tumor cell proliferation; epigenetic
inactivation of sFRP5 was reported to be associated with unfavourable
prognosis of human breast cancer (Veeck et al., 2008). It remains to be
established, if other members of the sFRP protein family can function
as multi-speciﬁc Wnt inhibitors with a broad range of speciﬁcity
comparable to the one of XsFRP5 (for a recent review on the
information available see Bovolenta et al., 2008).
A function for XsFRP5 in endodermal organ speciﬁcation and/or growth?
Xenopus sFRP5 knockdown embryos exhibited inhibition of
pancreas speciﬁcation, but nevertheless returned to almost normal
levels of Ptf1a/p48 and XlHbox8 staining during differentiation/
proliferation stages. Interestingly, a biphasic mode of Wnt-mediated
regulation has been postulated for pancreas development in the
mouse; early β-catenin activation prevents proper formation of
pancreatic precursor cells, whereas later in development, β-catenin
activation promotes proliferation and thereby gross enlargement of
the exocrine pancreas (Dessimoz et al., 2005; Heiser et al., 2006;
Murtaugh et al., 2005). In analogy, according to the results reported
in this communication, XsFRP5 could modulate a primary Wnt
signalling event in the context of pancreatic speciﬁcation control in
Xenopus embryos during tailbud stages of development, when
XsFRP5 expression overlaps with hepatic and ventral pancreatic
precursor cells (Pilcher and Krieg, 2002; Fig. 7). Furthermore, we also
observed an increased endodermal proliferation as a consequence of
XsFRP5 knockdown; such increased and perhaps premature prolif-
eration activity could thus possibly interfere with proper pancreas
speciﬁcation. However, at this point, we cannot exclude the
possibility of cell death contributing to the observed pancreas
hypoplasia.
Even though XsFRP5 is expressed in the foregut endoderm at the
time and place of hepatic induction in frogs and mice (Finley et al.,
2003; Pilcher and Krieg, 2002), we did not observe effects on
ﬁbrinogen expression in the liver and posterior endoderm of tadpole
stage Xenopus embryos upon XsFRP5 knockdown. Similarly, sFRP5
knockout has not been found to affect Hex expression that marks
hepatic precursor cells in the mouse (Leaf et al., 2006). These ﬁndingss in Xenopus. RA signalling is needed to establish a prepattern in the endodermal cell
m overlaps with the ventral pancreatic precursor cells andmight inhibit the function of a
sion is adjacent to mesodermal Xwnt2b expression, thereby modulating proliferative
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signalling in the anterior endoderm as being involved in hepatic
development, since other, redundant Wnt-antagonists, such as Dkk1,
Frzb1 and Crescent, could serve a similar function. Indeed, McLin et al.
(2007) reported that ectopic activation of canonical Wnt signalling in
the anterior endoderm bymeans of mRNA injection did interfere with
liver development, perhaps by direct repression of Hex expression.
Another possible explanation for the lack of an XsFRP5 knockdown
effect on liver development in the frog is provided by the assumption
that sFRPs act as modulators in the “ﬁne-tuning” of Wnt signalling,
with a knockdown resulting only in a moderate increase of
endogenous Wnt activities. Conversely, ectopic activation of Wnt
signalling as performed by McLin et al. (2007) is likely to result in a
robust increase of Wnt activity that then interferes with liver
development; liver speciﬁcation was disturbed at such relatively
high levels of Wnt signalling only when induced at early phases
(between gastrula and early somite stages) of development. Finally,
since the knockdown effect that we have obtained for XsFRP5 may
only be partial with some degree of XsFRP5 activity remaining in the
manipulated embryos, we cannot exclude the possibility of a
concentration-dependent function; in such a scenario, full inhibition
of XsFRP5 might be required to generate a liver phenotype.
Interestingly, after this study was initially submitted for publication,
a closely related analysis of XsFRP5 function in the context of foregut
speciﬁcation in Xenopuswas published and liver hypoplasia as a result
of XsFRP5 knockdown was indeed observed (Li et al., 2008); due to
different injection protocols, a higher effective MO dose was achieved,
providing an explanation for this apparent contradiction in respect to
the results obtained in their and our study.
A function for Wnt signalling in the choice between endocrine and
exocrine pancreatic fate?
We have previously demonstrated that RA signalling is essentially
required for normal pancreas development in the frog, but also for
the induction of endo- and exocrine pancreatic marker gene
expression in VegT-programmed animal cap explants (Chen et al.,
2004; Pan et al., 2007); in the absence of RA, VegT is sufﬁcient to
induce the liver-speciﬁc gene programme, including the liver
precursor cell marker Hex and the differentiation marker Ttr. VegT
injected animal cap explants express several different Wnt ligands
(data not shown); while coinjection of VegT and XsFRP5 did not
inhibit or increase Ttr expression as a marker gene for liver
differentiation, XsFRP5 was found to substitute for the need of RA
in respect to the induction of exocrine-, but not endocrine-speciﬁc
gene expression. In line with these observations, we have previously
observed that β-catenin enhances insulin expression in animal cap
explants (Pan et al., 2007) and McLin et al. (2007) reported that
repression of β-catenin signalling in the posterior endoderm results
in ectopic exocrine, but not endocrine pancreas development. The
exact molecular mechanism that is reﬂected in the functional link of
RA signalling and inhibition of Wnt signalling for the formation of
exocrine pancreatic tissue as reported in this communication remains
to be established, but these ﬁndings could be of interest for the
attempts in other cell systems to generate pancreatic cells from
multipotent precursor cells.
Xenopus Wnt2b: a target for XsFRP5 in the endoderm?
Both, functional assays and expression characteristics deﬁne
Xwnt2b as a primary candidate target protein for XsFRP5 in
organogenesis stage Xenopus embryos. Morpholino antisense oligo-
nucleotide mediated knockdown of Xwnt2b does indeed result in a
phenotype complementary to the one observed for XsFRP5 knock-
down, i.e. reduced rather than increased size of the developing
stomach at embryonic stage 40. One possible interpretation for thiseffect is that Xwnt2b signalling could positively regulate the growth of
this organ, and that this activity is negatively modulated by XsFRP5.
Mesenchymal expression of two other Wnt antagonists, sFRP1 and
sFRP2, was previously proposed to permit stomach epithelial diffe-
rentiation in the mouse (Kim et al., 2005), perhaps reﬂecting
inhibition of other Wnts in the context of later differentiation events
in this organ.
Similar to the effects observed upon knockdown of XsFRP5,
MO-mediated inhibition of Xwnt2b expression is also found to result
in pancreas hypoplasia. This effect could reﬂect a positive regulatory
function for Xwnt2b in the proliferation of the pancreas during later
stages of gut development, when XsFRP5 and Xwnt2b are expressed
in distinct territories. In line with such a scenario, we have found that
XsFRP5 exerts an early, negative regulatory role in proliferation, while
Xwnt2b has an opposite, stimulatory effect on endodermal prolifera-
tion in later stages of organogenesis. Interestingly, ectopic expression
of Wnt1 and Wnt5a under the control of the Pdx1 promoter in the
mouse is associated with stomach–duodenal re-patterning, pancreas
and spleen agenesis, as well as with a reduced size of pancreas, spleen
and stomach (Heller et al., 2002). This correlates with data obtained in
Xenopus, showing that early misexpression of canonical Wnt signal-
ling is inhibitory to foregut development (McLin et al., 2007), and it is
also in line with our own results, showing that the loss of the Wnt
antagonist XsFRP5 results in increased cell proliferation at stage 32
and a reduced ventral pancreatic anlage, most likely by de-repression
of early acting, endogenous Wnt signals. Non-neural expression of
Xwnt2b is ﬁrst detectable at stage 30 (Landesman and Sokol, 1997)
and the knockdown of Xwnt2b did not result in a signiﬁcant decrease
in cell proliferation before stage 37/38. As mentioned above, a
biphasic model for β-catenin signalling has been described for murine
pancreas development, with pancreatic hyperplasia when activated at
later stages (Heiser et al., 2006). In analogy, we propose that Xwnt2b
mediates its proliferative cues via canonical Wnt signalling during
later phases of endoderm patterning. Consistently, we found that
Xwnt2b morphant embryos expressed normal levels of Ptf1a/p48,
pointing towards unaffected pancreatic speciﬁcation, whereas the
expression of the exocrine differentiation marker XPDIp was grossly
reduced, perhaps resulting from decreased cell proliferation.
In conclusion, data reported in this study lead us to propose that,
during early embryonic development, XsFRP5 could exert a positive
function in the formation of pancreatic precursor cells by down-
regulating proliferation-promoting and speciﬁcation-inhibiting Wnt
signal(s), which remain to be identiﬁed. Li et al. (2008), in good
agreement with our own observations, reported that knockdown of
XsFRP5 results in hypoplastic ventral pancreatic buds; they further
demonstrate that increased Wnt11 signalling is responsible for this
effect. Thus, Wnt11 constitutes a prime candidate for the early acting
Wnt signal that needs to be repressed by XsFRP5 in order to allow for
proper pancreas speciﬁcation. During later stages of development,
proliferation of stomach and pancreas could be positively regulated by
Wnt signalling. In this phase of gut development, Xwnt2b is expressed
in the mesoderm adjacent to the pancreas/stomach forming endo-
derm (Fig. 7).
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